Comparing the soluble urokinase-type plasminogen activator receptor (suPAR) levels between individuals with subjective cognitive decline and mild cognitive impairment

被引：0
|
作者：
Batun, G. Cetiner [1 ]
Gultekin, G. [1 ]
Yuruyen, M. [2 ]
Yavuzer, H. [3 ]
Armutcu, F. [4 ]
Emul, M. [1 ]
Kocabasoglu, N. [1 ]
机构：
[1] Istanbul Univ, Med Sch Cerrahpasa, Psychiat, Istanbul, Turkey
[2] Istanbul Univ, Med Sch Cerrahpasa, Dept Geriatr, Istanbul, Turkey
[3] Istanbul Univ, Med Sch Cerrahpasa, Geriatr, Istanbul, Turkey
[4] Istanbul Univ, Med Sch Cerrahpasa, Biochem, Istanbul, Turkey
来源：
EUROPEAN NEUROPSYCHOPHARMACOLOGY | 2016年 / 26卷
关键词：
CANCER;
D O I：
10.1016/S0924-977X(16)31734-5
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P.5.a.004
引用
收藏
页码：S637 / S638
页数：2
相关论文
共 50 条
  • [1] Increased Soluble Urokinase-Type Plasminogen Activator Receptor (suPAR) Levels in Plasma of Suicide Attempters
    Ventorp, Filip
    Gustafsson, Anna
    Traskman-Bendz, Lil
    Westrin, Asa
    Ljunggren, Lennart
    PLOS ONE, 2015, 10 (10):
  • [2] Comparing the nesfatin-1 levels between individuals with subjective cognitive decline and mild cognitive impairment
    Gultekin, G.
    Batun, G. C.
    Yuruyen, M.
    Yavuzer, H.
    Akcan, F. E.
    Armutcu, F.
    Tosun, M.
    Emul, M.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2016, 26 : S203 - S204
  • [3] Comparing the alexithymia features between individuals with subjective cognitive decline and mild cognitive impairment
    Batun, G. Cetiner
    Gultekin, G.
    Yuruyen, M.
    Yavuzer, H.
    Akcan, F. Engin
    Emul, M.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2015, 25 : S583 - S583
  • [4] Soluble urokinase-type plasminogen activator receptor (suPAR) and interleukin-6 levels in hyperemesis gravidarum
    Desdicioglu, Raziye
    Yildirim, Melahat
    Kocaoglu, Gulcan
    Cendek, Busra Demir
    Avcioglu, Gamze
    Tas, Emre Erdem
    Sengul, Ozlem
    Erel, Ozcan
    Yavuz, Ayse Filiz
    JOURNAL OF THE CHINESE MEDICAL ASSOCIATION, 2018, 81 (09) : 825 - 829
  • [5] Soluble urokinase-type plasminogen activator receptor (SuPAR) in patients with Parkinson's disease
    Witek, N.
    Joyce, J.
    Hawkins, J.
    Liu, Y.
    Ouyang, B.
    Patel, R.
    Borgia, J.
    Reiser, J.
    Hall, D.
    MOVEMENT DISORDERS, 2021, 36 : S460 - S460
  • [6] Soluble urokinase-type plasminogen activator receptor (suPAR) is elevated in caregivers of patients with parkinsonism
    Joyce, Jessica
    Cabanas, Noel
    Pisharody, Rohan
    Ouyang, Bichun
    Patel, Roshni
    Reiser, Jochen
    Hall, Deborah A.
    Witek, Natalie
    PARKINSONISM & RELATED DISORDERS, 2022, 101 : 39 - 42
  • [7] Soluble urokinase-type plasminogen activator receptor and urokinase-type plasminogen activator receptor contribute to chemoresistance in leukemia
    Guo, Hong
    Zhou, Lan-Xia
    Ma, Haizhen
    Liu, Bei
    Cheng, Juan
    Ma, Yun-Yun
    Zhao, Li
    ONCOLOGY LETTERS, 2017, 14 (01) : 383 - 389
  • [8] Soluble urokinase-type plasminogen activator receptor (suPAR) - a possible biomarker for bacteremia in sepsis
    Georgescu, Anca-Meda
    Szederjesi, Janos
    Voidazan, Septimiu
    Dobreanu, Minodora
    Copotoiu, Sanda Maria
    Hutanu, Adina
    Azamfirei, Leonard
    REVISTA ROMANA DE MEDICINA DE LABORATOR, 2015, 23 (01): : 59 - 73
  • [9] Serum soluble urokinase-type plasminogen activator receptor (suPAR) levels in male patients with acute exacerbation of schizophrenia
    Genc, A.
    Kalelioglu, T.
    Karamustafalioglu, N.
    Tasdemir, A.
    Genc, E. Sena
    Akkus, M.
    Emul, M. H.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2015, 25 : S232 - S233
  • [10] Increased Serum Soluble Urokinase-Type Plasminogen Activator Receptor (suPAR) Levels in FSGS: A Meta-Analysis
    Lee, Jiwon M.
    Yang, Jae Won
    Kronbichler, Andreas
    Eisenhut, Michael
    Kim, Gaeun
    Lee, Keum Hwa
    Shin, Jae Il
    JOURNAL OF IMMUNOLOGY RESEARCH, 2019, 2019
12345